Filing Details

Accession Number:
0001567619-22-018437
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-12 14:01:11
Reporting Period:
2022-10-12
Accepted Time:
2022-10-12 14:01:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1505497 Biorestorative Therapies Inc. BRTX Services-Misc Health & Allied Services, Nec (8090) 911835664
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1527241 Francisco Silva 40 Marcus Drive
Melville NY 11747
Vp Of Research And Development Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-10-12 725 $3.39 165,103 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 12,136 Indirect IRA
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option $3,000.00 2022-12-07 1 1 Direct
Common Stock Stock Option $3,000.00 2023-10-04 1 1 Direct
Common Stock Stock Option $3,000.00 2024-02-18 3 3 Direct
Common Stock Stock Option $3,000.00 2014-03-12 2024-03-11 1 1 Direct
Common Stock Stock Option $3,000.00 2024-10-23 9 9 Direct
Common Stock Stock Option $3,000.00 2025-09-04 6 6 Direct
Common Stock Stock Option $3,000.00 2026-06-10 15 15 Direct
Common Stock Stock Option $3,000.00 2027-07-12 20 20 Direct
Common Stock Stock Option $3,000.00 2028-10-29 25 25 Direct
Common Stock Stock Option $13.50 2031-03-18 293,479 293,479 Direct
Common Stock Stock Option $13.50 2031-11-04 42,059 42,059 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-12-07 1 1 Direct
2023-10-04 1 1 Direct
2024-02-18 3 3 Direct
2024-03-11 1 1 Direct
2024-10-23 9 9 Direct
2025-09-04 6 6 Direct
2026-06-10 15 15 Direct
2027-07-12 20 20 Direct
2028-10-29 25 25 Direct
2031-03-18 293,479 293,479 Direct
2031-11-04 42,059 42,059 Direct
Footnotes
  1. Includes 104,045 shares received pursuant to unvested restricted stock unit grants. Such shares vest to the extent of 1,037 shares on each of October 18, 2022, December 18, 2022 and February 18, 2023, 1,036 shares on each of November 18, 2022 and January 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
  2. The option is currently exercisable.
  3. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 and the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
  4. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.